Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Deere & Company (DE) vs Tempus AI (TEM) Price & Performance

Deere & CompanyTrade

Price performance (Past 24H)

Key statistics

Deere & Company vs Tempus AI — how do they compare? Deere & Company trades at $652.58 (market cap $177.11B), while Tempus AI trades at $70.48 (market cap $12.77B). The key difference: Deere & Company is far larger — about 13.9× Tempus AI's market cap, and Deere & Company pays a 0.99% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Deere & Company for 75 Days and Tempus AI for 22 Days on average.

DETEM
Market Cap
$177.11B$12.77B
Volume
1,206,3088,980,490
Sector
IndustrialsBroad Market / Factor
52-Week High
$709.48$99.28
52-Week Low
$439.11$41.55
Typical Hold Time
75 Days22 Days
Enterprise Value
$231.01B$13.40B
Dividend Yield
0.99%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Deere & Company

Deere & Company (DE) trades at $656.87, down 3.8% on the day, reflecting near-term pressure amid a broader bearish technical signal. The stock has demonstrated strong earnings momentum, beating estimates in the last three quarters, but faces headwinds from declining revenue and net income margins. Recent news highlights the company's focus on AI-driven agricultural solutions to counter cyclical downturns, while analyst consensus remains divided with a price target of $731.20 suggesting potential upside from current levels.

The outlook for DE is mixed; solid profitability metrics and consistent cash flow generation support the investment case, but cyclical exposure to agriculture equipment demand and elevated valuation ratios pose risks. Earnings growth and successful execution of technology initiatives are key catalysts for outperformance, though macroeconomic volatility could dampen near-term returns.

Tempus AI

Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.

Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DE
100% Buy0% Sell
Avg holding period · 75 Days
TEM
24% Buy76% Sell
Avg holding period · 22 Days

Top news

Latest headlines on both assets

About Deere & Company

Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.

Read more on DE →

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM →